CorMedix Inc.
CRMD
$10.32
$0.545.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,647.68% | 14,970.65% | -- | -- | 41,186.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,647.68% | 14,970.65% | -- | -- | 41,186.87% |
| Cost of Revenue | 521.54% | 296.70% | 378.53% | -- | 490,650.00% |
| Gross Profit | 1,862.30% | 22,354.90% | 9,707.46% | -- | 35,051.19% |
| SG&A Expenses | 44.72% | 14.81% | 33.70% | 63.94% | 102.53% |
| Depreciation & Amortization | 6,891.33% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.54% | 22.43% | 24.59% | 34.46% | 51.59% |
| Operating Income | 303.98% | 184.82% | 126.49% | 54.34% | -22.27% |
| Income Before Tax | 325.13% | 194.81% | 133.27% | 58.30% | -19.47% |
| Income Tax Expenses | -3,876.58% | 137.39% | 100.00% | -- | -- |
| Earnings from Continuing Operations | 452.12% | 196.32% | 134.20% | 61.31% | -15.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 452.12% | 196.32% | 134.20% | 61.31% | -15.97% |
| EBIT | 303.98% | 184.82% | 126.49% | 54.34% | -22.27% |
| EBITDA | 313.13% | 185.95% | 127.35% | 54.90% | -22.02% |
| EPS Basic | 381.60% | 184.18% | 126.09% | 64.53% | 6.43% |
| Normalized Basic EPS | 283.86% | 182.84% | 125.43% | 61.88% | 3.60% |
| EPS Diluted | 354.59% | 180.44% | 123.55% | 63.74% | 5.59% |
| Normalized Diluted EPS | 269.89% | 179.29% | 123.64% | 61.88% | 3.60% |
| Average Basic Shares Outstanding | 16.97% | 10.67% | 12.17% | 15.76% | 23.14% |
| Average Diluted Shares Outstanding | 24.76% | 14.04% | 13.89% | 15.76% | 23.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |